EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Research progress on N6-methyladenosine RNA modification in osteosarcoma: functions, mechanisms, and potential clinical applications

Ying Yang, Wen-Juan Ni, Yadong Yang, Junnan Liao, Yuqian Yang, Jianwei Li, Xiuzhi Zhu, Chun Guo, Fuhua Xie, Xiao-Min Leng

Medical Oncology · 2025

DOI: 10.1007/s12032-024-02597-x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Oncology, 2025. Verfasst von Ying Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Gannan Medical University, Ganzhou, 341000, Jiangxi, China. Hauptthemen laut MEDLINE: Osteosarcoma, Adenosine, Bone Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 99 Literaturangaben. Gefördert von: Graduate Innovation Program of Gannan Medical University, Science and Technology Research Project of Jiangxi Provincial Department of Education, Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular of Ministry of Education of Gannan Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma (OS) is the most commonly diagnosed primary malignant bone tumor in children and adolescents. Despite significant advancements in therapeutic strategies against OS over the past few decades, the prognosis for this disease remains poor, largely due to its high invasiveness and challenges associated with its treatment. N6-methyladenosine (m6A) modification is one of the most abundant epigenetic modifications of RNAs, and many studies have highlighted its crucial role in OS. This article provides a comprehensive summary and introduction to m6A regulators, including methyltransferases, demethylases, and binding proteins. The article emphasizes how regulated m6A modifications can either promote or inhibit OS. It also delves into the mechanisms by which m6A-modified messenger RNAs (mRNAs) and noncoding RNAs (ncRNAs) participate in signaling pathways such as the Wnt/β-catenin, PI3K/AKT, and STAT3 pathways, and discusses these mechanisms in detail. Given the abnormal expression of m6A regulators in OS, the article also explores their potential applications as biomarkers or therapeutic targets in clinical settings. It is anticipated that this review will provide new insights into the diagnosis and treatment of OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaAdenosineBone NeoplasmsHumansEpigenesis, GeneticRNA, MessengerAnimalsSignal TransductionGene Expression Regulation, NeoplasticBiomarkers, Tumor

Stichwörter der Autor:innen

M6A regulatorM6A-modified ncRNAN6-methyladenosineOsteosarcoma

Substanzen

AdenosineN-methyladenosineRNA, MessengerBiomarkers, Tumor

Autor:innen und Institutionen

  • School of Basic Medicine, Gannan Medical University, Ganzhou, 341000, Jiangxi, China.
  • Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular of Ministry of Education, Gannan Medical University, Ganzhou, 341000, Jiangxi, China.
  • The First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, Jiangxi, China.
  • Modern Industrial College of Biomedicine and Great Health, Youjiang Medical University for Nationalities, 98 Chengxiang Road, Youjiang District, Baise, 533000, Guangxi, China.
  • Department of Human Anatomy, School of Basic Medical Sciences, Youjiang Medical University for Nationalities, 98 Chengxiang Road, Youjiang District, Baise, 533000, Guangxi, People's Republic of China.
  • School of Basic Medicine, Gannan Medical University, Ganzhou, 341000, Jiangxi, China. lengxm@mail2.sysu.edu.cn.

Förderung

  • Graduate Innovation Program of Gannan Medical University
  • Science and Technology Research Project of Jiangxi Provincial Department of Education
  • Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular of Ministry of Education of Gannan Medical University
  • Startup Foundation for Advanced Talents of Gannan Medical University

Zitieren

APA

Yang, Y., Ni, W. J., Yang, Y., Liao, J., Yang, Y., Li, J., Zhu, X., Guo, C., Xie, F., & Leng, X. M. (2025). Research progress on N6-methyladenosine RNA modification in osteosarcoma: functions, mechanisms, and potential clinical applications. Medical Oncology. https://doi.org/10.1007/s12032-024-02597-x

Vancouver

Yang Y, Ni WJ, Yang Y, Liao J, Yang Y, Li J, et al. Research progress on N6-methyladenosine RNA modification in osteosarcoma: functions, mechanisms, and potential clinical applications. Medical Oncology. 2025. doi:10.1007/s12032-024-02597-x

BibTeX
@article{Yang2025,
  author = {Yang, Ying and Ni, Wen-Juan and Yang, Yadong and Liao, Junnan and Yang, Yuqian and Li, Jianwei and Zhu, Xiuzhi and Guo, Chun and Xie, Fuhua and Leng, Xiao-Min},
  title = {Research progress on N6-methyladenosine RNA modification in osteosarcoma: functions, mechanisms, and potential clinical applications},
  journal = {Medical Oncology},
  year = {2025},
  doi = {10.1007/s12032-024-02597-x}
}
Kostenlos starten →